SlideShare una empresa de Scribd logo
1 de 65
Descargar para leer sin conexión
Acute infectious
diarrhea
Prepared by :-
Mohammed Musa
Mohammed Saadi
Hussein Jassam
Mahmoud Ahmed
Meran Salih
Learning Objectives
2
▰ Define acute infectious diarrhea
▰ Create a differential diagnosis for acute diarrhea
▰ Investigation and Clinical assessment
▰ Discuss treatment options including
symptom management
3
1
Definition
Diarrhoea
4
▰ Diarrhoea is defined as the passage of more than 200g of stool daily
and measurement of stool volume is helpful in confirming this.
▰ The most severe symptom in many patients is urgency of defecation,
and faecal incontinence is a common event in acute and chronic
diarrhoeal illnesses
Acute diarrhea
5
▰ This is extremely common and is usually caused by faecal–oral
transmission of bacteria or their toxins, viruses or parasites.
▰ Infective diarrhoea is usually short-lived and patients who present with
a history of diarrhoea lasting more than 10 days rarely have an
infective cause.
▰ A variety of drugs, including antibiotics, cytotoxic drugs, PPIs and
NSAIDs, may be responsible.
6
▰ Acute diarrhoea, sometimes with vomiting, is the predominant
symptom in infective gastroenteritis.
▰ Acute diarrhoea may also be a symptom of other infectious and
non-infectious diseases.
▰ Stress, whether psychological or physical, can also produce loose
stools.
7
2
Pathophysiology
of Diarrhea
Secretory Diarrhea
8
▰ Large volumes of water are normally secreted into the small intestinal
lumen, but a large majority of this water is efficiently absorbed before
reaching the large intestine.
▰ Diarrhea occurs when secretion of water into the intestinal lumen
exceeds absorption.
Secretory Diarrhea
9
▰ Many millions of people have died of the secretory diarrhea.
associated with cholera. The responsible organism, Vibrio cholerae,
produces cholera toxin, which strongly activates adenylyl cyclase,
causing a prolonged increase in intracellular concentration of cyclic
AMP within crypt enterocytes.
▰ This change results in prolonged opening of the chloride channels that
are instrumental in secretion of water from the crypts, allowing
uncontrolled secretion of water. Additionally, cholera toxin affects
the enteric nervous system, resulting in an independent stimulus of
secretion.
Secretory Diarrhea
10
▰ Exposure to toxins from several other types of bacteria (e.g. E.
coli heat-labile toxin) induce the same series of steps and massive
secretory diarrhea that is often lethal unless the person is aggressively
treated to maintain hydration.
▰ In addition to bacterial toxins, a large number of other agents can
induce secretory diarrhea by turning on the intestinal secretory
machinery, including:
▰ some laxatives, hormones, drugs, certain metals, organic toxins, and
plant products (e.g. arsenic, insecticides, mushroom toxins, caffeine)
▰ In most cases, secretory diarrheas will not resolve
during a 2-3 day fast.
Inflammatory and Infectious Diarrhea
11
▰ The epithelium of the digestive tube is protected from insult by a
number of mechanisms constituting the gastrointestinal barrier, but
like many barriers, it can be breached.
▰ Disruption of the epithelium of the intestine due to microbial or viral
pathogens is a very common cause of diarrhea in all species.
▰ Destruction of the epithelium results not only in exudation of serum
and blood into the lumen but often is associated with widespread
destruction of absorptive epithelium.
▰ In such cases, absorption of water occurs very inefficiently and
diarrhea results.
Inflammatory and Infectious Diarrhea
12
▰ Examples of pathogens frequently associated with infectious diarrhea
include:
▻ Bacteria: Salmonella, E. coli, Campylobacter
▻ Viruses: rotaviruses, norovirus
▻ Protozoa: Giardia, Cryptosporium,
Inflammatory and Infectious Diarrhea
13
▰ The immune response to inflammatory conditions in the bowel
contributes substantively to development of diarrhea.
▰ Activation of white blood cells leads them to secrete inflammatory
mediators and cytokines which can stimulate secretion, in effect
imposing a secretory component on top of an inflammatory diarrhea.
▰ Reactive oxygen species from leukocytes can damage or kill intestinal
epithelial cells, which are replaced with immature cells that typically
are deficient in the brush border enyzmes and transporters necessary
for absorption of nutrients and water. In this way, components of an
osmotic (malabsorption) diarrhea are added to the problem.
Osmotic diarrhea
14
It is the diarrhea that occurs due to the ingestion of poorly absorbed
osmotically active substances that cause shifting of the water into the
intestinal lumen
▻ If you stop oral feeding the diarrhea will stop.
▰ Can be Occur in:
1.ingestion of high CHO diet.
2-Congenital Lactase deficiency (primary)
3.infection with rotavirus or Salmonella, Enter hemorrhagic E.coli
causes severe shedding of villi that contains Disaccharidases
enzyme (secondary lactase deficiency).
Dysmotility/Functional diarrhea
15
▰ Gut dysmotility may cause increased intestinal and colonic transit
time as well as decrease contact time with intestinal absorptive
mucosa.
▰ Functional syndromes such as irritable bowel syndrome (IBS) include
a pain component as well as a change in bowel habits.
16
3
Epidemiology
Epidemiology
17
▰ Diarrhoeal disease is the second leading cause of death in
children under five years old. It is both preventable and treatable.
▰ The World Health Organisation (WHO) estimates that there are
more than 1.7 billion cases of acute diarrhoea annually globally.
▰ Each year diarrhoea kills around
760 000 children under five.
▰ In developed countries, diarrhoea remains
an important problem, with the elderly being
most vulnerable.
18
4
Etiology
19
Causes of Acute infectious diarrhea
20
▰ Gram –ve bacillus
▰ Normal commensal in human gut Virulent types-
▰ Enterotoxigenic - leading cause of watery diarrhea, most common
cause of travellers’ diarrhea
▰ Enteropathogenic- diarrhea with mucus
▰ Enteroinvasive- profuse diarrhea with fever
▰ Enterohemorrhagic - dysentery, can cause HUS Enteroaggregative-
watery diarrhea
21
Escherichia coli
▰ Caused by bacteria Vibrio cholerae Primarily affects small-intestine
▰ People with O blood group more affected, carriers of cystic fibrosis are
protected??
▰ Toxin leads to cAMP activation causing secretion of water, Na, K, Cl &
HCO3
▰ Causes profuse diarrhea (rice water),
▰ with abdominal pain, ± vomiting
22
Cholera
23
Cholera
24
Cholera
25
▰ A gram –ve bacillus
▰ Causes diarrhea with mild fever or TYPHOID- enteric fever
▰ Stages- each lasting ~1 week
Salmonella typhi
WIDAL TEST
26
1 Mild fever, relative bradycardia, malaise, leucopenia, blood culture
+ve, Widal test –ve
2 High fever, Rose spots on trunk, delirium, bradycardia,
diarrhea (occasionally constipation), HSmegaly,
blood culture/Widal test +ve
3 High fever, delirium, complications- hemorrhage, perforation,
peritonitis, cholecystitis, metastatic abscess
4 Resolution/Defervescence
27
Salmonella typhi
28
Salmonella typhi
Campylobacter
▰ Typically caused by Campylobacter jejuni
▻ or C. coli; it is largely a foodborne disease.
▰ Primarily uncooked poultry
▰ Diarrhea (bloody ~10%), abdominal pain
30
Campylobacter
31
• Fever with chills
• Abdominal cramps
• Diarrhea often with blood and mucus
• Headache, malaise
• Direct person-to-person spread
• Tx Trimethoprim-
▻ sulfamethoxazole, ciprofloxin, levofloxacin, ampicillin
• Increasing resistance to antibiotics noted
• Azithromycin, 500mg orally on day 1 and 250mg orally one time a day
for 4 days, may be an effective alternative treatment
for resistant strains
Shigellosis
32
• Clostridium difficile
• 20% chance after completing broad spectrum antibiotic
• The A and B toxins produced by C. difficile can cause severe diarrhea,
pseudomembranous colitis, or toxic megacolon.
• High risk pts: nursing home residents and employees, hospitalized pts and
employees
• metronidazole (250mg orally four times a day or 500mg orally three times
a day for 10 days)
CLOSTRIDIUM DIFFICILE
33
CLOSTRIDIUM DIFFICILE
35
5
Clinical
assessment
Clinical assessment
36
▰ The history should address foods ingested, duration and frequency of
diarrhoea, presence of blood or steatorrhoea, abdominal pain and
tenesmus, and whether other people have been affected.
▰ Fever and bloody diarrhoea suggest an invasive, colitic, dysenteric
process.
▰ An incubation period of less than 18 hours suggests toxin-mediated
food poisoning, and longer than 5 days suggests diarrhoea caused by
protozoa or helminthes.
▰ Person-to-person spread suggests certain infections,
such asshigellosis or cholera.
Foods associated with infectious illness,
including gastroenteritis
37
Foods associated with infectious illness,
including gastroenteritis
38
Clinical assessment
39
▰ Examination includes assessment of the degree of dehydration.
▰ Assessment for early signs of hypotension, such as thirst, headache,
altered skin turgor, dry mucous membranes and postural hypotension,
is important, particularly in tropical regions where dehydration
progresses rapidly.
▰ Signs of more marked dehydration include supine hypotension and
tachycardia, decreased urinary output, delirium and sunken eyes.
▰ The blood pressure, pulse rate, urine output and ongoing stool losses
should be monitored closely.
40
Clinical assessment
41
▰ The severity of diarrhoea may be assessed by reference to the Bristol
stool form scale (Bristol stool chart), which allows an objective
assessment of stool consistency by providing a verbal and visual
reference scale.
▰ The Bristol stool form scale was developed in the 1990s to monitor
patients with irritable bowel syndrome, but its main use (at least in UK
hospitals) is to monitor hospital inpatients with loose stool to assist in
decisions on stool sampling and infection prevention precautions,
especially in relation to C. difficile.
Bristol stool chart
▰ The stool is given a ‘score’ of 1–7 by
▰ reference to the verbal and visual
description.
▰ This is recorded on a chart (usually known
as a ‘Bristol stool chart’) or in a patient
monitoring database.
42
Bristol stool chart
43
Investigations
44
These include stool inspection for blood and microscopy for leucocytes,
and also an examination for ova, cysts and parasites if the history indicates
residence or travel to areas where these infections are prevalent.
▰ Stool culture should be performed and C. difficile toxin sought.
▰ FBC and serum electrolytes indicate the degree of inflammation and
dehydration.
▰ Where cholera is prevalent, examination of a wet film with dark-field
microscopy for darting motility may provide a diagnosis.
▰ In a malarious area, a blood film for malaria parasites
should be obtained.
45
Investigations
46
▰ Blood and urine cultures and a chest X-ray may identify alternative
sites of infection, particularly if the clinical features suggest a
syndrome other than gastroenteritis.
Investigations
47
▰ Structural examination by sigmoidoscopy, colonoscopy, or abdominal
computed tomography (CT) scanning (or other imaging approaches)
may be appropriate in patients with uncharacterized persistent
diarrhea to exclude IBD or as an initial approach in patients with
suspected noninfectious acute diarrhea such as ischemic colitis,
diverticulitis, or partial bowel obstruction.
48
6
Management
Management
49
▰ All patients with acute, potentially infective diarrhoea should be
appropriately isolated to minimise person-to-person spread of
infection.
▰ If the history suggests a food-borne source, public health measures
must be implemented to identify the source and to establish whether
other linked cases exist.
Fluid replacement
50
▰ Replacement of fluid losses in diarrheal illness is crucial and may be life-
saving.
▰ Although normal daily fluid intake in an adult is only 1–2 L, there is
considerable additional fluid movement in and out of the gut in
secretions.
▰ Altered gut resorption with diarrhea can result in substantial fluid loss;
for example, 10–20 L of fluid may be lost in 24 hours in cholera.
▰ The fluid lost in diarrhea is isotonic, so both water and electrolytes need
to be replaced.
51
Fluid homeostasis in the gastrointestinal
tract.
• Absorption of electrolytes from the
gut is an active process requiring
energy.
• Infected mucosa is capable of very
rapid fluid and electrolyte transport
if carbohydrate is available as an
energy source.
Fluid replacement
52
▰ Oral rehydration solutions (ORS) therefore contain sugars, as well as
water and electrolytes.
▰ ORS can be just as effective as intravenous replacement fluid, even in
the management of cholera.
▰ In mild to moderate gastroenteritis, adults should be encouraged to
drink fluids and, if possible, continue normal dietary food intake.
▰ If this is impossible – due to vomiting, for example – intravenous fluid
administration will be required.
▰ In very sick patients or
those with cardiac or
renal disease,
monitoring of urine
output and central
venous pressure may
be necessary.
53
Fluid replacement
Fluid replacement
54
The volume of fluid replacement required should be estimated based on
the following considerations:
▰ Replacement of established deficit
▰ Replacement of ongoing losses
▰ Replacement of normal daily requirement
Fluid replacement
55
Replacement of established deficit
▰ After 48 hours of moderate diarrhoea (6–10 stools per 24 hrs), the
average adult will be 2–4 L depleted from diarrhoea alone. Associated
vomiting will compound this.
▰ Adults with this symptomatology should therefore be given rapid
replacement of 1–1.5 L, either orally (ORS) or by intravenous infusion
(normal saline), within the first 2–4 hours of presentation.
▰ Longer symptomatology or more persistent/severe diarrhoea rapidly
produces fluid losses comparable to diabetic ketoacidosis and is a
metabolic emergency requiring active intervention.
Fluid replacement
56
Replacement of ongoing losses
▰ The average adult’s diarrheal stool accounts for a loss of 200 mL of
isotonic fluid.
▰ Stool losses should be carefully charted and an estimate of ongoing
replacement fluid calculated.
▰ Commercially available rehydration sachets are conveniently produced
to provide 200 mL of ORS; one sachet per diarrhoea stool is an
appropriate estimate of supplementary replacement requirements.
Fluid replacement
57
Replacement of normal daily requirement
▰ The average adult has a daily requirement of 1–1.5 L of fluid in
addition to the previous calculations.
▰ This will be increased substantially in fever or a hot environment.
Antimicrobial agents
58
▰ In non-specific gastroenteritis, routine use of antimicrobials does not
improve outcome and may lead to antimicrobial resistance or side-
effects.
▰ They are usually used where there is systemic involvement, a host with
immunocompromise or significant comorbidity.
▰ Evidence suggests that, in Enterohaemorrhagic Escherichia coli (EHEC)
infections, the use of antibiotics may make the complication of
haemolytic uraemic syndrome (HUS) more likely due to increased toxin
release. Antibiotics should therefore not be used in
this condition.
Antimicrobial agents
59
▰ Conversely, antibiotics are indicated in Shigella dysenteriae infection
and in invasive salmonellosis – in particular, typhoid fever.
▰ Antibiotics may also be advantageous in cholera epidemics, reducing
infectivity and controlling the spread of infection.
Antidiarrhoeal, antimotility and
antisecretory agents
60
▰ These agents are not usually recommended in acute infective
diarrhoea.
▰ Loperamide, diphenoxylate and opiates are potentially dangerous
in dysentery in childhood, causing intussusception.
▰ Antisecretory agents, such as bismuth and chlorpromazine, may
make the stools appear more bulky but do not reduce stool fluid losses
and may cause significant sedation.
▰ Adsorbents, such as kaolin or charcoal, have little effect.
61
7
Prevention
▰ Good hygiene, hand washing,
safe food preparation, and
access to clean water are key
factors in preventing diarrheal
illness.
▰ Vaccine development remains
a high priority for disease
prevention.
▰ Effective and safe vaccines
exist for rotavirus, typhoid
fever, and cholera, and are
under investigation for
Campylobacter,
enterotoxigenic E. coli,
and Shigella infections.
62
Prevention
63
Take Home Message
▰ Infectious diarrhoea is due to faeco–oral transmission of viruses,
bacteria, bacterial toxins or parasites.
▰ Most cases are self-limiting and a pathogen is rarely identified.
▰ Viruses and toxins causes large-volume watery diarrhoea.
▰ Invasive intestinal pathogens (cause bloody diarrhoea)
▰ Clostridium difficile infection (CDI) (cause hospital-acquired diarrhoea).
▰ Diarrhoea that persists for >10 days is unlikely to be infective.
▰ Consider protozoal infections in patients who are immunocompromised
or have recently travelled to the tropics.
References:
64
Thank you
65

Más contenido relacionado

La actualidad más candente

Gastroenteritis
GastroenteritisGastroenteritis
GastroenteritisAnne Odaro
 
Malabsorption in tropical sprue & coeliac disease
Malabsorption in tropical sprue & coeliac diseaseMalabsorption in tropical sprue & coeliac disease
Malabsorption in tropical sprue & coeliac diseaseautumnpianist
 
An approach to a patient with chronic diarrhea
An approach to a patient with chronic diarrhea An approach to a patient with chronic diarrhea
An approach to a patient with chronic diarrhea Rawalpindi Medical College
 
Diarrhea
DiarrheaDiarrhea
Diarrheafitango
 
Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017
Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017
Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017Kemi Dele-Ijagbulu
 
Management of chronic diarrhea
Management of chronic diarrheaManagement of chronic diarrhea
Management of chronic diarrheaANGAN KARMAKAR
 
Acute gastroenteritis
Acute gastroenteritis  Acute gastroenteritis
Acute gastroenteritis Pediatrics
 
Acute Poststreptococcal Glomerulonephritis
Acute Poststreptococcal GlomerulonephritisAcute Poststreptococcal Glomerulonephritis
Acute Poststreptococcal GlomerulonephritisHakimah Suhaimi
 
Gastroenteritis
GastroenteritisGastroenteritis
Gastroenteritisali7070
 
Acute glomerulonephritis for UGs
Acute glomerulonephritis for UGsAcute glomerulonephritis for UGs
Acute glomerulonephritis for UGsCSN Vittal
 
Acute diarrhea in children MBBS Lecture
Acute diarrhea in children MBBS Lecture Acute diarrhea in children MBBS Lecture
Acute diarrhea in children MBBS Lecture Sajjad Sabir
 

La actualidad más candente (20)

approach to a patient with Chronic diarrhoea
approach to a patient with Chronic diarrhoeaapproach to a patient with Chronic diarrhoea
approach to a patient with Chronic diarrhoea
 
Acute diarrhoea
Acute diarrhoeaAcute diarrhoea
Acute diarrhoea
 
Gastroenteritis
GastroenteritisGastroenteritis
Gastroenteritis
 
Chronic diarrhea
Chronic diarrhea  Chronic diarrhea
Chronic diarrhea
 
Diarrhea ppt
Diarrhea pptDiarrhea ppt
Diarrhea ppt
 
Travellers diarrhea
Travellers diarrheaTravellers diarrhea
Travellers diarrhea
 
L7 chronic gastritis f
L7 chronic gastritis fL7 chronic gastritis f
L7 chronic gastritis f
 
Malabsorption in tropical sprue & coeliac disease
Malabsorption in tropical sprue & coeliac diseaseMalabsorption in tropical sprue & coeliac disease
Malabsorption in tropical sprue & coeliac disease
 
An approach to a patient with chronic diarrhea
An approach to a patient with chronic diarrhea An approach to a patient with chronic diarrhea
An approach to a patient with chronic diarrhea
 
Diarrhea
DiarrheaDiarrhea
Diarrhea
 
Mallory weiss syndrome
Mallory weiss syndromeMallory weiss syndrome
Mallory weiss syndrome
 
Chronic diarrhea
Chronic diarrhea Chronic diarrhea
Chronic diarrhea
 
Chronic liver disease
Chronic liver diseaseChronic liver disease
Chronic liver disease
 
Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017
Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017
Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017
 
Management of chronic diarrhea
Management of chronic diarrheaManagement of chronic diarrhea
Management of chronic diarrhea
 
Acute gastroenteritis
Acute gastroenteritis  Acute gastroenteritis
Acute gastroenteritis
 
Acute Poststreptococcal Glomerulonephritis
Acute Poststreptococcal GlomerulonephritisAcute Poststreptococcal Glomerulonephritis
Acute Poststreptococcal Glomerulonephritis
 
Gastroenteritis
GastroenteritisGastroenteritis
Gastroenteritis
 
Acute glomerulonephritis for UGs
Acute glomerulonephritis for UGsAcute glomerulonephritis for UGs
Acute glomerulonephritis for UGs
 
Acute diarrhea in children MBBS Lecture
Acute diarrhea in children MBBS Lecture Acute diarrhea in children MBBS Lecture
Acute diarrhea in children MBBS Lecture
 

Similar a Acute infectious diarrhea diagnosis and treatment

Similar a Acute infectious diarrhea diagnosis and treatment (20)

Approach to Diarrhea and constipation
 Approach to Diarrhea and constipation  Approach to Diarrhea and constipation
Approach to Diarrhea and constipation
 
Gastroenteritis.pptx
Gastroenteritis.pptxGastroenteritis.pptx
Gastroenteritis.pptx
 
Acute Diarrhea 22-08-2022.pptx
Acute Diarrhea 22-08-2022.pptxAcute Diarrhea 22-08-2022.pptx
Acute Diarrhea 22-08-2022.pptx
 
Bacterial diarrhea 2013 4th year unza medical,by DR MWANSA
Bacterial diarrhea 2013 4th year unza medical,by DR MWANSABacterial diarrhea 2013 4th year unza medical,by DR MWANSA
Bacterial diarrhea 2013 4th year unza medical,by DR MWANSA
 
Symptomatic treatment of Diarrhea
Symptomatic treatment of DiarrheaSymptomatic treatment of Diarrhea
Symptomatic treatment of Diarrhea
 
diarrhoeal disorders.pptx
diarrhoeal disorders.pptxdiarrhoeal disorders.pptx
diarrhoeal disorders.pptx
 
Effective treatment for Diarrhoea at Mindheal Homeopathy
Effective treatment for Diarrhoea at Mindheal HomeopathyEffective treatment for Diarrhoea at Mindheal Homeopathy
Effective treatment for Diarrhoea at Mindheal Homeopathy
 
Diarrhoea | www.mindheal.org
Diarrhoea | www.mindheal.orgDiarrhoea | www.mindheal.org
Diarrhoea | www.mindheal.org
 
diarrhea n malabsorption.pptx
diarrhea n malabsorption.pptxdiarrhea n malabsorption.pptx
diarrhea n malabsorption.pptx
 
Presentation1 1
Presentation1 1Presentation1 1
Presentation1 1
 
Gastroenteritis
GastroenteritisGastroenteritis
Gastroenteritis
 
Pediatric gastroenteritis 1
Pediatric gastroenteritis 1Pediatric gastroenteritis 1
Pediatric gastroenteritis 1
 
Pediatric gastroenteritis 1
Pediatric gastroenteritis 1Pediatric gastroenteritis 1
Pediatric gastroenteritis 1
 
Diarrhea
DiarrheaDiarrhea
Diarrhea
 
Acute diarrhea.pptx
Acute diarrhea.pptxAcute diarrhea.pptx
Acute diarrhea.pptx
 
Diarrhea clinical diagnosis
Diarrhea clinical diagnosisDiarrhea clinical diagnosis
Diarrhea clinical diagnosis
 
Diarrhoea
DiarrhoeaDiarrhoea
Diarrhoea
 
Git 6th acute diarrhea
Git 6th acute diarrheaGit 6th acute diarrhea
Git 6th acute diarrhea
 
Git 6th acute diarrhea
Git 6th acute diarrheaGit 6th acute diarrhea
Git 6th acute diarrhea
 
DIARRHEA (1).pptx
DIARRHEA (1).pptxDIARRHEA (1).pptx
DIARRHEA (1).pptx
 

Más de Mohammed Musa

Coronavirus disease (COVID-19)
Coronavirus disease (COVID-19)Coronavirus disease (COVID-19)
Coronavirus disease (COVID-19)Mohammed Musa
 
Gilbert & Budd-Chiari Syndrome
Gilbert & Budd-Chiari SyndromeGilbert & Budd-Chiari Syndrome
Gilbert & Budd-Chiari SyndromeMohammed Musa
 
PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)Mohammed Musa
 
Radiological differential diagnosis by mohammed musa 1st ed
Radiological differential diagnosis by mohammed musa 1st edRadiological differential diagnosis by mohammed musa 1st ed
Radiological differential diagnosis by mohammed musa 1st edMohammed Musa
 
Haematemesis and malena
Haematemesis and malenaHaematemesis and malena
Haematemesis and malenaMohammed Musa
 
Drug resistance against malaria
Drug resistance against malariaDrug resistance against malaria
Drug resistance against malariaMohammed Musa
 
Acute respiratory infection (ARI)
Acute respiratory infection (ARI)Acute respiratory infection (ARI)
Acute respiratory infection (ARI)Mohammed Musa
 
Generalized oedema & Proteinuria
Generalized oedema & ProteinuriaGeneralized oedema & Proteinuria
Generalized oedema & ProteinuriaMohammed Musa
 

Más de Mohammed Musa (13)

Coronavirus disease (COVID-19)
Coronavirus disease (COVID-19)Coronavirus disease (COVID-19)
Coronavirus disease (COVID-19)
 
Gilbert & Budd-Chiari Syndrome
Gilbert & Budd-Chiari SyndromeGilbert & Budd-Chiari Syndrome
Gilbert & Budd-Chiari Syndrome
 
Dyspepsia
DyspepsiaDyspepsia
Dyspepsia
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Hemostasis
HemostasisHemostasis
Hemostasis
 
PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)
 
Radiological differential diagnosis by mohammed musa 1st ed
Radiological differential diagnosis by mohammed musa 1st edRadiological differential diagnosis by mohammed musa 1st ed
Radiological differential diagnosis by mohammed musa 1st ed
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Haematemesis and malena
Haematemesis and malenaHaematemesis and malena
Haematemesis and malena
 
Drug resistance against malaria
Drug resistance against malariaDrug resistance against malaria
Drug resistance against malaria
 
Acute respiratory infection (ARI)
Acute respiratory infection (ARI)Acute respiratory infection (ARI)
Acute respiratory infection (ARI)
 
Coma in pediatric
Coma in pediatricComa in pediatric
Coma in pediatric
 
Generalized oedema & Proteinuria
Generalized oedema & ProteinuriaGeneralized oedema & Proteinuria
Generalized oedema & Proteinuria
 

Último

Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 

Último (20)

Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 

Acute infectious diarrhea diagnosis and treatment

  • 1. Acute infectious diarrhea Prepared by :- Mohammed Musa Mohammed Saadi Hussein Jassam Mahmoud Ahmed Meran Salih
  • 2. Learning Objectives 2 ▰ Define acute infectious diarrhea ▰ Create a differential diagnosis for acute diarrhea ▰ Investigation and Clinical assessment ▰ Discuss treatment options including symptom management
  • 4. Diarrhoea 4 ▰ Diarrhoea is defined as the passage of more than 200g of stool daily and measurement of stool volume is helpful in confirming this. ▰ The most severe symptom in many patients is urgency of defecation, and faecal incontinence is a common event in acute and chronic diarrhoeal illnesses
  • 5. Acute diarrhea 5 ▰ This is extremely common and is usually caused by faecal–oral transmission of bacteria or their toxins, viruses or parasites. ▰ Infective diarrhoea is usually short-lived and patients who present with a history of diarrhoea lasting more than 10 days rarely have an infective cause. ▰ A variety of drugs, including antibiotics, cytotoxic drugs, PPIs and NSAIDs, may be responsible.
  • 6. 6 ▰ Acute diarrhoea, sometimes with vomiting, is the predominant symptom in infective gastroenteritis. ▰ Acute diarrhoea may also be a symptom of other infectious and non-infectious diseases. ▰ Stress, whether psychological or physical, can also produce loose stools.
  • 8. Secretory Diarrhea 8 ▰ Large volumes of water are normally secreted into the small intestinal lumen, but a large majority of this water is efficiently absorbed before reaching the large intestine. ▰ Diarrhea occurs when secretion of water into the intestinal lumen exceeds absorption.
  • 9. Secretory Diarrhea 9 ▰ Many millions of people have died of the secretory diarrhea. associated with cholera. The responsible organism, Vibrio cholerae, produces cholera toxin, which strongly activates adenylyl cyclase, causing a prolonged increase in intracellular concentration of cyclic AMP within crypt enterocytes. ▰ This change results in prolonged opening of the chloride channels that are instrumental in secretion of water from the crypts, allowing uncontrolled secretion of water. Additionally, cholera toxin affects the enteric nervous system, resulting in an independent stimulus of secretion.
  • 10. Secretory Diarrhea 10 ▰ Exposure to toxins from several other types of bacteria (e.g. E. coli heat-labile toxin) induce the same series of steps and massive secretory diarrhea that is often lethal unless the person is aggressively treated to maintain hydration. ▰ In addition to bacterial toxins, a large number of other agents can induce secretory diarrhea by turning on the intestinal secretory machinery, including: ▰ some laxatives, hormones, drugs, certain metals, organic toxins, and plant products (e.g. arsenic, insecticides, mushroom toxins, caffeine) ▰ In most cases, secretory diarrheas will not resolve during a 2-3 day fast.
  • 11. Inflammatory and Infectious Diarrhea 11 ▰ The epithelium of the digestive tube is protected from insult by a number of mechanisms constituting the gastrointestinal barrier, but like many barriers, it can be breached. ▰ Disruption of the epithelium of the intestine due to microbial or viral pathogens is a very common cause of diarrhea in all species. ▰ Destruction of the epithelium results not only in exudation of serum and blood into the lumen but often is associated with widespread destruction of absorptive epithelium. ▰ In such cases, absorption of water occurs very inefficiently and diarrhea results.
  • 12. Inflammatory and Infectious Diarrhea 12 ▰ Examples of pathogens frequently associated with infectious diarrhea include: ▻ Bacteria: Salmonella, E. coli, Campylobacter ▻ Viruses: rotaviruses, norovirus ▻ Protozoa: Giardia, Cryptosporium,
  • 13. Inflammatory and Infectious Diarrhea 13 ▰ The immune response to inflammatory conditions in the bowel contributes substantively to development of diarrhea. ▰ Activation of white blood cells leads them to secrete inflammatory mediators and cytokines which can stimulate secretion, in effect imposing a secretory component on top of an inflammatory diarrhea. ▰ Reactive oxygen species from leukocytes can damage or kill intestinal epithelial cells, which are replaced with immature cells that typically are deficient in the brush border enyzmes and transporters necessary for absorption of nutrients and water. In this way, components of an osmotic (malabsorption) diarrhea are added to the problem.
  • 14. Osmotic diarrhea 14 It is the diarrhea that occurs due to the ingestion of poorly absorbed osmotically active substances that cause shifting of the water into the intestinal lumen ▻ If you stop oral feeding the diarrhea will stop. ▰ Can be Occur in: 1.ingestion of high CHO diet. 2-Congenital Lactase deficiency (primary) 3.infection with rotavirus or Salmonella, Enter hemorrhagic E.coli causes severe shedding of villi that contains Disaccharidases enzyme (secondary lactase deficiency).
  • 15. Dysmotility/Functional diarrhea 15 ▰ Gut dysmotility may cause increased intestinal and colonic transit time as well as decrease contact time with intestinal absorptive mucosa. ▰ Functional syndromes such as irritable bowel syndrome (IBS) include a pain component as well as a change in bowel habits.
  • 17. Epidemiology 17 ▰ Diarrhoeal disease is the second leading cause of death in children under five years old. It is both preventable and treatable. ▰ The World Health Organisation (WHO) estimates that there are more than 1.7 billion cases of acute diarrhoea annually globally. ▰ Each year diarrhoea kills around 760 000 children under five. ▰ In developed countries, diarrhoea remains an important problem, with the elderly being most vulnerable.
  • 19. 19 Causes of Acute infectious diarrhea
  • 20. 20
  • 21. ▰ Gram –ve bacillus ▰ Normal commensal in human gut Virulent types- ▰ Enterotoxigenic - leading cause of watery diarrhea, most common cause of travellers’ diarrhea ▰ Enteropathogenic- diarrhea with mucus ▰ Enteroinvasive- profuse diarrhea with fever ▰ Enterohemorrhagic - dysentery, can cause HUS Enteroaggregative- watery diarrhea 21 Escherichia coli
  • 22. ▰ Caused by bacteria Vibrio cholerae Primarily affects small-intestine ▰ People with O blood group more affected, carriers of cystic fibrosis are protected?? ▰ Toxin leads to cAMP activation causing secretion of water, Na, K, Cl & HCO3 ▰ Causes profuse diarrhea (rice water), ▰ with abdominal pain, ± vomiting 22 Cholera
  • 25. 25 ▰ A gram –ve bacillus ▰ Causes diarrhea with mild fever or TYPHOID- enteric fever ▰ Stages- each lasting ~1 week Salmonella typhi
  • 27. 1 Mild fever, relative bradycardia, malaise, leucopenia, blood culture +ve, Widal test –ve 2 High fever, Rose spots on trunk, delirium, bradycardia, diarrhea (occasionally constipation), HSmegaly, blood culture/Widal test +ve 3 High fever, delirium, complications- hemorrhage, perforation, peritonitis, cholecystitis, metastatic abscess 4 Resolution/Defervescence 27 Salmonella typhi
  • 29. Campylobacter ▰ Typically caused by Campylobacter jejuni ▻ or C. coli; it is largely a foodborne disease. ▰ Primarily uncooked poultry ▰ Diarrhea (bloody ~10%), abdominal pain
  • 31. 31 • Fever with chills • Abdominal cramps • Diarrhea often with blood and mucus • Headache, malaise • Direct person-to-person spread • Tx Trimethoprim- ▻ sulfamethoxazole, ciprofloxin, levofloxacin, ampicillin • Increasing resistance to antibiotics noted • Azithromycin, 500mg orally on day 1 and 250mg orally one time a day for 4 days, may be an effective alternative treatment for resistant strains Shigellosis
  • 32. 32 • Clostridium difficile • 20% chance after completing broad spectrum antibiotic • The A and B toxins produced by C. difficile can cause severe diarrhea, pseudomembranous colitis, or toxic megacolon. • High risk pts: nursing home residents and employees, hospitalized pts and employees • metronidazole (250mg orally four times a day or 500mg orally three times a day for 10 days) CLOSTRIDIUM DIFFICILE
  • 34.
  • 36. Clinical assessment 36 ▰ The history should address foods ingested, duration and frequency of diarrhoea, presence of blood or steatorrhoea, abdominal pain and tenesmus, and whether other people have been affected. ▰ Fever and bloody diarrhoea suggest an invasive, colitic, dysenteric process. ▰ An incubation period of less than 18 hours suggests toxin-mediated food poisoning, and longer than 5 days suggests diarrhoea caused by protozoa or helminthes. ▰ Person-to-person spread suggests certain infections, such asshigellosis or cholera.
  • 37. Foods associated with infectious illness, including gastroenteritis 37
  • 38. Foods associated with infectious illness, including gastroenteritis 38
  • 39. Clinical assessment 39 ▰ Examination includes assessment of the degree of dehydration. ▰ Assessment for early signs of hypotension, such as thirst, headache, altered skin turgor, dry mucous membranes and postural hypotension, is important, particularly in tropical regions where dehydration progresses rapidly. ▰ Signs of more marked dehydration include supine hypotension and tachycardia, decreased urinary output, delirium and sunken eyes. ▰ The blood pressure, pulse rate, urine output and ongoing stool losses should be monitored closely.
  • 40. 40
  • 41. Clinical assessment 41 ▰ The severity of diarrhoea may be assessed by reference to the Bristol stool form scale (Bristol stool chart), which allows an objective assessment of stool consistency by providing a verbal and visual reference scale. ▰ The Bristol stool form scale was developed in the 1990s to monitor patients with irritable bowel syndrome, but its main use (at least in UK hospitals) is to monitor hospital inpatients with loose stool to assist in decisions on stool sampling and infection prevention precautions, especially in relation to C. difficile.
  • 42. Bristol stool chart ▰ The stool is given a ‘score’ of 1–7 by ▰ reference to the verbal and visual description. ▰ This is recorded on a chart (usually known as a ‘Bristol stool chart’) or in a patient monitoring database. 42
  • 44. Investigations 44 These include stool inspection for blood and microscopy for leucocytes, and also an examination for ova, cysts and parasites if the history indicates residence or travel to areas where these infections are prevalent. ▰ Stool culture should be performed and C. difficile toxin sought. ▰ FBC and serum electrolytes indicate the degree of inflammation and dehydration. ▰ Where cholera is prevalent, examination of a wet film with dark-field microscopy for darting motility may provide a diagnosis. ▰ In a malarious area, a blood film for malaria parasites should be obtained.
  • 45. 45
  • 46. Investigations 46 ▰ Blood and urine cultures and a chest X-ray may identify alternative sites of infection, particularly if the clinical features suggest a syndrome other than gastroenteritis.
  • 47. Investigations 47 ▰ Structural examination by sigmoidoscopy, colonoscopy, or abdominal computed tomography (CT) scanning (or other imaging approaches) may be appropriate in patients with uncharacterized persistent diarrhea to exclude IBD or as an initial approach in patients with suspected noninfectious acute diarrhea such as ischemic colitis, diverticulitis, or partial bowel obstruction.
  • 49. Management 49 ▰ All patients with acute, potentially infective diarrhoea should be appropriately isolated to minimise person-to-person spread of infection. ▰ If the history suggests a food-borne source, public health measures must be implemented to identify the source and to establish whether other linked cases exist.
  • 50. Fluid replacement 50 ▰ Replacement of fluid losses in diarrheal illness is crucial and may be life- saving. ▰ Although normal daily fluid intake in an adult is only 1–2 L, there is considerable additional fluid movement in and out of the gut in secretions. ▰ Altered gut resorption with diarrhea can result in substantial fluid loss; for example, 10–20 L of fluid may be lost in 24 hours in cholera. ▰ The fluid lost in diarrhea is isotonic, so both water and electrolytes need to be replaced.
  • 51. 51 Fluid homeostasis in the gastrointestinal tract. • Absorption of electrolytes from the gut is an active process requiring energy. • Infected mucosa is capable of very rapid fluid and electrolyte transport if carbohydrate is available as an energy source.
  • 52. Fluid replacement 52 ▰ Oral rehydration solutions (ORS) therefore contain sugars, as well as water and electrolytes. ▰ ORS can be just as effective as intravenous replacement fluid, even in the management of cholera. ▰ In mild to moderate gastroenteritis, adults should be encouraged to drink fluids and, if possible, continue normal dietary food intake. ▰ If this is impossible – due to vomiting, for example – intravenous fluid administration will be required.
  • 53. ▰ In very sick patients or those with cardiac or renal disease, monitoring of urine output and central venous pressure may be necessary. 53 Fluid replacement
  • 54. Fluid replacement 54 The volume of fluid replacement required should be estimated based on the following considerations: ▰ Replacement of established deficit ▰ Replacement of ongoing losses ▰ Replacement of normal daily requirement
  • 55. Fluid replacement 55 Replacement of established deficit ▰ After 48 hours of moderate diarrhoea (6–10 stools per 24 hrs), the average adult will be 2–4 L depleted from diarrhoea alone. Associated vomiting will compound this. ▰ Adults with this symptomatology should therefore be given rapid replacement of 1–1.5 L, either orally (ORS) or by intravenous infusion (normal saline), within the first 2–4 hours of presentation. ▰ Longer symptomatology or more persistent/severe diarrhoea rapidly produces fluid losses comparable to diabetic ketoacidosis and is a metabolic emergency requiring active intervention.
  • 56. Fluid replacement 56 Replacement of ongoing losses ▰ The average adult’s diarrheal stool accounts for a loss of 200 mL of isotonic fluid. ▰ Stool losses should be carefully charted and an estimate of ongoing replacement fluid calculated. ▰ Commercially available rehydration sachets are conveniently produced to provide 200 mL of ORS; one sachet per diarrhoea stool is an appropriate estimate of supplementary replacement requirements.
  • 57. Fluid replacement 57 Replacement of normal daily requirement ▰ The average adult has a daily requirement of 1–1.5 L of fluid in addition to the previous calculations. ▰ This will be increased substantially in fever or a hot environment.
  • 58. Antimicrobial agents 58 ▰ In non-specific gastroenteritis, routine use of antimicrobials does not improve outcome and may lead to antimicrobial resistance or side- effects. ▰ They are usually used where there is systemic involvement, a host with immunocompromise or significant comorbidity. ▰ Evidence suggests that, in Enterohaemorrhagic Escherichia coli (EHEC) infections, the use of antibiotics may make the complication of haemolytic uraemic syndrome (HUS) more likely due to increased toxin release. Antibiotics should therefore not be used in this condition.
  • 59. Antimicrobial agents 59 ▰ Conversely, antibiotics are indicated in Shigella dysenteriae infection and in invasive salmonellosis – in particular, typhoid fever. ▰ Antibiotics may also be advantageous in cholera epidemics, reducing infectivity and controlling the spread of infection.
  • 60. Antidiarrhoeal, antimotility and antisecretory agents 60 ▰ These agents are not usually recommended in acute infective diarrhoea. ▰ Loperamide, diphenoxylate and opiates are potentially dangerous in dysentery in childhood, causing intussusception. ▰ Antisecretory agents, such as bismuth and chlorpromazine, may make the stools appear more bulky but do not reduce stool fluid losses and may cause significant sedation. ▰ Adsorbents, such as kaolin or charcoal, have little effect.
  • 62. ▰ Good hygiene, hand washing, safe food preparation, and access to clean water are key factors in preventing diarrheal illness. ▰ Vaccine development remains a high priority for disease prevention. ▰ Effective and safe vaccines exist for rotavirus, typhoid fever, and cholera, and are under investigation for Campylobacter, enterotoxigenic E. coli, and Shigella infections. 62 Prevention
  • 63. 63 Take Home Message ▰ Infectious diarrhoea is due to faeco–oral transmission of viruses, bacteria, bacterial toxins or parasites. ▰ Most cases are self-limiting and a pathogen is rarely identified. ▰ Viruses and toxins causes large-volume watery diarrhoea. ▰ Invasive intestinal pathogens (cause bloody diarrhoea) ▰ Clostridium difficile infection (CDI) (cause hospital-acquired diarrhoea). ▰ Diarrhoea that persists for >10 days is unlikely to be infective. ▰ Consider protozoal infections in patients who are immunocompromised or have recently travelled to the tropics.